Samumed to Release Phase 2 Results at AAD

An important bit of news surfaced online this weekend about the company Samumed and their heralded phase 2 results. Samumed will be presenting “Safety, Tolerability and Efficacy of a Topical Treatment (SM04554) for Androgenetic Alopecia (AGA): Results from a Phase 2 Trial” on March 5th, 2016 at the 74th Annual Meeting of the American Academy…

Read More

COL17A1, Foxc1, Brotzu: Weekly Thoughts 2/8/16

Hello everybody, nice to be back here with you again. There seems to have been a surge of hair growth related news as of late which makes it a great time to do some reporting. Without further ado, here are your Weekly Thoughts. COL17A1 and Hair Follicle Aging A major key to understanding the process…

Read More